Aditi Bhargava
Jan 31, 2022

--

If you can please clarify:

1) which vaccine are you specifically talking about that was tested in Brazil.

2) Efficacy was evaluated how many days after dose 2.

3) was this a randomized RCT and was the placebo group maintained as placebo?

4) how long were the participants followed for and what was the rate of breakthrough cases?

--

--

Aditi Bhargava

Dr. Aditi Bhargava is a molecular neuroendocrinologist with research focus on sex differences in stress biology and immunology.